ASR Nederland NV (XAMS:ASRNL) Research & Development: €0 Mil (TTM As of Dec. 2025)


XAMS:ASRNL ASR Nederland NV XAMS:ASRNL
62 GF Score
Price €66.16
GF Value €41.47
Valuation Significantly Overvalued
! 12 Warning Signs
View Full Analysis

What is ASR Nederland NV Research & Development?

ASR Nederland NV XAMS:ASRNL +0.18% 62 Research & Development is €0 Mil as of Dec. 2025. GuruFocus rates XAMS:ASRNL with a GF Score™ of 62/100 and a GF Value™ of €41.47 (Significantly Overvalued). The stock has 12 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. ASR Nederland NV's Research & Development for the six months ended in Dec. 2025 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0 Mil.

ASR Nederland NV  (XAMS:ASRNL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

ASR Nederland NV Research & Development Related Terms

ASR Nederland NV Research & Development Historical Data

* Premium members only.

The historical data trend for ASR Nederland NV's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASR Nederland NV Research & Development Chart

ASR Nederland NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ASR Nederland NV Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XAMS:ASRNL
62GF Score
ASR Nederland NV XAMS:ASRNL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ASR Nederland NV Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
ASR Nederland NV (XAMS:ASRNL) has a Research & Development of €0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on ASR Nederland NV and its competitors.
Is ASR Nederland NV's Research & Development too high?
ASR Nederland NV's current Research & Development is €0 Mil. Overall, ASR Nederland NV has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ASR Nederland NV's Research & Development compare to BRK.A and AIG?
ASR Nederland NV's Research & Development of €0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on ASR Nederland NV and its competitors. ASR Nederland NV's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASR Nederland NV stock overvalued right now?
Based on GuruFocus' analysis, ASR Nederland NV (XAMS:ASRNL) is currently considered Significantly Overvalued. The stock's GF Value™ is €41.47, compared to a current price of €66.16 — trading 59.5% above its estimated fair value. The current Research & Development is €0 Mil. ASR Nederland NV's overall GF Score™ is 62/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For ASR Nederland NV (XAMS:ASRNL), the current Research & Development is €0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ASR Nederland NV (XAMS:ASRNL) Overvalued in 2026?

Based on GuruFocus' analysis, ASR Nederland NV stock appears to be overvalued. The current stock price of €66.16 is trading 59.5% above its estimated GF Value™ of €41.47. GuruFocus considers ASR Nederland NV to be Significantly Overvalued.

Key valuation signals for XAMS:ASRNL:

  • Research & Development: €0 Mil
  • GF Value™: €41.47 vs. price of €66.16 (59.5% above fair value)
  • GF Score™: 62/100 with 12 warning signs

No single metric tells the full story. See the XAMS:ASRNL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ASR Nederland NV Business Description

Address Archimedeslaan 10, P.O. Box 2072, Utrecht, UT, NLD, 3500 HB
ASR Nederland NV is an insurance company. The company offers a variety of insurance policies to its customers. The business segments are Non-life; Life; Banking, Asset Management; Distribution and Services and Holding and Other. The Non-life insurance entities offer Non-life insurance contracts. Its life insurance entities offer financial products such as life insurance contracts and life insurance contracts on behalf of policyholders. The Asset Management segment involves all activities related to asset management including investment property management. Its Distribution and Services segment includes activities related to the distribution of insurance contracts.
62GF Score

Get the complete analysis for XAMS:ASRNL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€66.16
Price
€41.47
GF Value